ReP USP - Resultado da busca

Artigo de periodico
New directions in antimalarial target validation (2020)
Batista, Fernando de Assis ; Gyau, Benjamin; Santos, Juliana Fátima Vilachã Madeira Rodrigues dos ; Bosch, Soraya Soraya ; Lunev, Sergey ; Wrenger, Carsten ; Groves, Matthew R.
Source: Expert Opinion on Drug Discovery. Unidade: ICB
Subjects: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, PLASMA DE ANIMAL, AMINOÁCIDOS, PLASMODIUM FALCIPARUM, MAPEAMENTO GENÉTICO, POLIPEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA, Fernando de Assis et al. New directions in antimalarial target validation. Expert Opinion on Drug Discovery, v. 15, n. 2, p. 189–202, 2020Tradução . . Disponível em: https://doi.org/10.1080/17460441.2020.1691996. Acesso em: 23 maio 2024.
APA
Batista, F. de A., Gyau, B., Santos, J. F. V. M. R. dos, Bosch, S. S., Lunev, S., Wrenger, C., & Groves, M. R. (2020). New directions in antimalarial target validation. Expert Opinion on Drug Discovery, 15( 2), 189–202. doi:10.1080/17460441.2020.1691996
NLM
Batista F de A, Gyau B, Santos JFVMR dos, Bosch SS, Lunev S, Wrenger C, Groves MR. New directions in antimalarial target validation [Internet]. Expert Opinion on Drug Discovery. 2020 ; 15( 2): 189–202.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2020.1691996
Vancouver
Batista F de A, Gyau B, Santos JFVMR dos, Bosch SS, Lunev S, Wrenger C, Groves MR. New directions in antimalarial target validation [Internet]. Expert Opinion on Drug Discovery. 2020 ; 15( 2): 189–202.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2020.1691996
Artigo de periodico
Advances with support vector machines for novel drug discovery (2019)
Maltarollo, Vinicius Gonçalves; Kronenberger, Thales; Espinoza, Gabriel Zarzana; Oliveira, Patricia Rufino; Honorio, Kathia Maria
Source: Expert Opinion on Drug Discovery. Unidade: EACH
Subjects: QUÍMICA MÉDICA, PLANEJAMENTO DE FÁRMACOS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinicius Gonçalves et al. Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, v. 14, n. Ja 2019, p. 01-11, 2019Tradução . . Disponível em: https://doi.org/10.1080/17460441.2019.1549033. Acesso em: 23 maio 2024.
APA
Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R., & Honorio, K. M. (2019). Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, 14( Ja 2019), 01-11. doi:10.1080/17460441.2019.1549033
NLM
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Vancouver
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Artigo de periodico
Developing animal models of Zika virus infection for novel drug discovery (2019)
Ohki, Cristine Marie Yde; Benazzato, Cecilia; Russo, Fabiele Baldino; Beltrão-Braga, Patrícia
Source: Expert Opinion on Drug Discovery. Unidades: EACH, ICB, FMVZ
Subjects: ZIKA VÍRUS, PLANEJAMENTO DE FÁRMACOS, ZIKA VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHKI, Cristine Marie Yde et al. Developing animal models of Zika virus infection for novel drug discovery. Expert Opinion on Drug Discovery, v. 14, n. 6, p. 577-589, 2019Tradução . . Disponível em: https://doi.org/10.1080/17460441.2019.1597050. Acesso em: 23 maio 2024.
APA
Ohki, C. M. Y., Benazzato, C., Russo, F. B., & Beltrão-Braga, P. (2019). Developing animal models of Zika virus infection for novel drug discovery. Expert Opinion on Drug Discovery, 14( 6), 577-589. doi:10.1080/17460441.2019.1597050
NLM
Ohki CMY, Benazzato C, Russo FB, Beltrão-Braga P. Developing animal models of Zika virus infection for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( 6): 577-589.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2019.1597050
Vancouver
Ohki CMY, Benazzato C, Russo FB, Beltrão-Braga P. Developing animal models of Zika virus infection for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( 6): 577-589.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2019.1597050
Artigo de periodico
Use of machine learning approaches for novel drug discovery (2016)
Lima, Angélica Nakagawa; Philot, Eric Alisson; Trossini, Gustavo Henrique Goulart ; Scott, Luis Paulo Barbour; Maltarollo, Vinícius Gonçalves; Honório, Kathia Maria
Source: Expert Opinion on Drug Discovery. Unidades: FCF, EACH
Subjects: HISTOPLASMA, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Angélica Nakagawa et al. Use of machine learning approaches for novel drug discovery. Expert Opinion on Drug Discovery, v. 11, n. 3, p. 225-239, 2016Tradução . . Disponível em: https://doi.org/10.1517/17460441.2016.1146250. Acesso em: 23 maio 2024.
APA
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honório, K. M. (2016). Use of machine learning approaches for novel drug discovery. Expert Opinion on Drug Discovery, 11( 3), 225-239. doi:10.1517/17460441.2016.1146250
NLM
Lima AN, Philot EA, Trossini GHG, Scott LPB, Maltarollo VG, Honório KM. Use of machine learning approaches for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 3): 225-239.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441.2016.1146250
Vancouver
Lima AN, Philot EA, Trossini GHG, Scott LPB, Maltarollo VG, Honório KM. Use of machine learning approaches for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 3): 225-239.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441.2016.1146250
Artigo de periodico
Protein-protein interaction inhibitors: advances in anticancer drug design (2016)
Ferreira, Leonardo G.; Oliva, Glaucius; Andricopulo, Adriano Defini
Source: Expert Opinion on Drug Discovery. Unidade: IFSC
Subjects: PROTEÍNAS, CRISTALOGRAFIA DE RAIOS X, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo G. e OLIVA, Glaucius e ANDRICOPULO, Adriano Defini. Protein-protein interaction inhibitors: advances in anticancer drug design. Expert Opinion on Drug Discovery, v. 11, n. 10, p. 957-968, 2016Tradução . . Disponível em: https://doi.org/10.1080/17460441.2016.1223038. Acesso em: 23 maio 2024.
APA
Ferreira, L. G., Oliva, G., & Andricopulo, A. D. (2016). Protein-protein interaction inhibitors: advances in anticancer drug design. Expert Opinion on Drug Discovery, 11( 10), 957-968. doi:10.1080/17460441.2016.1223038
NLM
Ferreira LG, Oliva G, Andricopulo AD. Protein-protein interaction inhibitors: advances in anticancer drug design [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 10): 957-968.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2016.1223038
Vancouver
Ferreira LG, Oliva G, Andricopulo AD. Protein-protein interaction inhibitors: advances in anticancer drug design [Internet]. Expert Opinion on Drug Discovery. 2016 ; 11( 10): 957-968.[citado 2024 maio 23 ] Available from: https://doi.org/10.1080/17460441.2016.1223038
Artigo de periodico
In silico screening strategies for novel inhibitors of parasitic diseases (2011)
Ferreira, Rafaela S.; Guido, Rafael Victorio Carvalho; Andricopulo, Adriano Defini; Oliva, Glaucius
Source: Expert Opinion on Drug Discovery. Unidade: IFSC
Subjects: DOENÇAS PARASITÁRIAS (ESTUDO;TRATAMENTO), PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafaela S. et al. In silico screening strategies for novel inhibitors of parasitic diseases. Expert Opinion on Drug Discovery, v. 6, n. 5, p. 481-489, 2011Tradução . . Disponível em: https://doi.org/10.1517/17460441.2011.563297. Acesso em: 23 maio 2024.
APA
Ferreira, R. S., Guido, R. V. C., Andricopulo, A. D., & Oliva, G. (2011). In silico screening strategies for novel inhibitors of parasitic diseases. Expert Opinion on Drug Discovery, 6( 5), 481-489. doi:10.1517/17460441.2011.563297
NLM
Ferreira RS, Guido RVC, Andricopulo AD, Oliva G. In silico screening strategies for novel inhibitors of parasitic diseases [Internet]. Expert Opinion on Drug Discovery. 2011 ; 6( 5): 481-489.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441.2011.563297
Vancouver
Ferreira RS, Guido RVC, Andricopulo AD, Oliva G. In silico screening strategies for novel inhibitors of parasitic diseases [Internet]. Expert Opinion on Drug Discovery. 2011 ; 6( 5): 481-489.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441.2011.563297
Artigo de periodico
Fragment-based QSAR strategies in drug design (2010)
Salum, Livia B.; Andricopulo, Adriano Defini
Source: Expert Opinion on Drug Discovery. Unidade: IFSC
Subjects: QUÍMICA MÉDICA, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALUM, Livia B. e ANDRICOPULO, Adriano Defini. Fragment-based QSAR strategies in drug design. Expert Opinion on Drug Discovery, v. 5, n. 5, p. 405-412, 2010Tradução . . Disponível em: https://doi.org/10.1517/17460441003782277. Acesso em: 23 maio 2024.
APA
Salum, L. B., & Andricopulo, A. D. (2010). Fragment-based QSAR strategies in drug design. Expert Opinion on Drug Discovery, 5( 5), 405-412. doi:10.1517/17460441003782277
NLM
Salum LB, Andricopulo AD. Fragment-based QSAR strategies in drug design [Internet]. Expert Opinion on Drug Discovery. 2010 ; 5( 5): 405-412.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441003782277
Vancouver
Salum LB, Andricopulo AD. Fragment-based QSAR strategies in drug design [Internet]. Expert Opinion on Drug Discovery. 2010 ; 5( 5): 405-412.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441003782277
Artigo de periodico
The GRID/CPCA approach in drug discovery (2010)
Rocha, Josmar R; Freitas, Renato F; Montanari, Carlos Alberto
Source: Expert Opinion on Drug Discovery. Unidade: IQSC
Assunto: QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Josmar R e FREITAS, Renato F e MONTANARI, Carlos Alberto. The GRID/CPCA approach in drug discovery. Expert Opinion on Drug Discovery, v. 5, n. 4, p. 333-346, 2010Tradução . . Disponível em: https://doi.org/10.1517/17460441003652959. Acesso em: 23 maio 2024.
APA
Rocha, J. R., Freitas, R. F., & Montanari, C. A. (2010). The GRID/CPCA approach in drug discovery. Expert Opinion on Drug Discovery, 5( 4), 333-346. doi:10.1517/17460441003652959
NLM
Rocha JR, Freitas RF, Montanari CA. The GRID/CPCA approach in drug discovery [Internet]. Expert Opinion on Drug Discovery. 2010 ; 5( 4): 333-346.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441003652959
Vancouver
Rocha JR, Freitas RF, Montanari CA. The GRID/CPCA approach in drug discovery [Internet]. Expert Opinion on Drug Discovery. 2010 ; 5( 4): 333-346.[citado 2024 maio 23 ] Available from: https://doi.org/10.1517/17460441003652959

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Indexado em